Favorable patent ruling for Illumina
Blog Post
- Published: Mar 22, 2013
- Author: Jon Evans
- Channels: Sample Preparation / Gas Chromatography / Laboratory Informatics / HPLC / Detectors / Ion Chromatography / Proteomics & Genomics / Electrophoresis / UV/Vis Spectroscopy / Base Peak / X-ray Spectrometry / Raman / MRI Spectroscopy / Chemometrics & Informatics / Proteomics / NMR Knowledge Base / Atomic / Infrared Spectroscopy
A US district court judge has ruled that genetic sequencing systems developed by the US company Illumina do not infringe three patents held by fellow US company Life Technologies.
'We are obviously very pleased with the favorable outcome of this suit,' said Jay Flatley, Illumina’s president and CEO. 'Since Life Technologies filed this patent infringement suit against Illumina in 2009, we have consistently believed and strongly argued that our sequencing technology does not infringe any of the patents Life Technologies asserted against us in this case.'
Comments
There are currently no comments on this post.
Comment Form
You have to log in to comment on this post.
Log in using the form at the top of the page or register here.